The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Pedro Cuevas Sánchez

Departamento de Investigación

IRYCIS

Hospital Universitario Ramón y Cajal

Ctra, de Colmenar

Spain

[email]@hrc.es

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Departamento de Investigación, IRYCIS, Hospital Universitario Ramón y Cajal, Ctra, de Colmenar, Spain. 1997 - 2012
  • Servicio de Histología, IRYCIS, E-28034 Madrid, Spain. 2011

References

  1. Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy. Cuevas, P., Outeiriño, L.A., Azanza, C., Angulo, J., Giménez-Gallego, G. Eur. J. Med. Res. (2012) [Pubmed]
  2. Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor. Cuevas, P., Carceller, F., Angulo, J., González-Corrochano, R., Cuevas-Bourdier, A., Giménez-Gallego, G. Neurosci. Lett. (2011) [Pubmed]
  3. Topical treatment of actinic keratoses with potassium dobesilate 5% cream. a preliminary open-label study. Cuevas Sánchez, P., Espinoza, W., Pérez, C., Angulo, J., Giménez-Gallego, G. Eur. J. Med. Res. (2011) [Pubmed]
  4. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells. Cuevas, P., Díaz-González, D., Sánchez, I., Lozano, R.M., Giménez-Gallego, G., Dujovny, M. Neurol. Res. (2006) [Pubmed]
  5. Dobesilate diminishes activation of the mitogen-activated protein kinase ERK1/2 in glioma cells. Cuevas, P., Díaz-González, D., García-Martín-Córdova, C., Sánchez, I., Lozano, R.M., Giménez-Gallego, G., Dujovny, M. J. Cell. Mol. Med. (2006) [Pubmed]
  6. Topical treatment of basal cell carcinoma with neomycin. Cuevas, P., Arrazola, J.M. Eur. J. Med. Res. (2005) [Pubmed]
  7. Dobesilate is an angiogenesis inhibitor. Cuevas, P., Sanchez, I., Lozano, R.M., Gimenez-Gallego, G. Eur. J. Med. Res. (2005) [Pubmed]
  8. Dobesilate in the treatment of plaque psoriasis. Cuevas, P., Arrazola, J.M. Eur. J. Med. Res. (2005) [Pubmed]
  9. Therapeutic response of rosacea to dobesilate. Cuevas, P., Arrazola, J.M. Eur. J. Med. Res. (2005) [Pubmed]
  10. Dihydroxy-2,5 benzenesulphonate (dobesilate) elicits growth arrest and apoptosis in glioma cells. Cuevas, P., Díaz-González, D., Giménez-Gallego, G., Dujovny, M. Neurol. Res. (2005) [Pubmed]
  11. Bone marrow stromal cell implantation for peripheral nerve repair. Cuevas, P., Carceller, F., Garcia-Gómez, I., Yan, M., Dujovny, M. Neurol. Res. (2004) [Pubmed]
  12. Neomycin inhibits glioma cell migration. Cuevas, P., Díaz-González, D., Dujovny, M. Neurol. Res. (2004) [Pubmed]
  13. Differentiation-inducing activity of neomycin in cultured rat glioma cells. Cuevas, P., Díaz-González, D., Dujovny, M. Neurol. Res. (2004) [Pubmed]
  14. Dual blockade of mitogen-activated protein kinases ERK-1 (p42) and ERK-2 (p44) and cyclic AMP response element binding protein (CREB) by neomycin inhibits glioma cell proliferation. Cuevas, P., Diaz-González, D., Carceller, F., Dujovny, M. Neurol. Res. (2003) [Pubmed]
  15. Glioma cell-associated sustained activation of the transcription factor, nuclear factor-kappa B, was inhibited by neomycin. Cuevas, P., Díaz-González, D., Dujovny, M. Neurol. Res. (2003) [Pubmed]
  16. Antiproliferative action of neomycin is associated with inhibition of cyclin D1 activation in glioma cells. Cuevas, P., Díaz-González, D., Dujovny, M. Neurol. Res. (2003) [Pubmed]
  17. Antiproliferative effect of neomycin in glioma cells. Cuevas, P., Diaz-González, D., Dujovny, M. Neurol. Res. (2002) [Pubmed]
  18. Inhibition of rat glioma growth by neomycin. Preliminary report. Cuevas, P., Carceller, F., Diaz-González, D., Cuevas, B., Fernández, A., Garcia-Gómez, I., Dujovny, M. Neurol. Res. (2002) [Pubmed]
  19. Peripheral nerve regeneration by bone marrow stromal cells. Cuevas, P., Carceller, F., Dujovny, M., Garcia-Gómez, I., Cuevas, B., González-Corrochano, R., Diaz-González, D., Reimers, D. Neurol. Res. (2002) [Pubmed]
  20. Therapeutic implications of fibroblast growth factors in traumatic spinal cord injury. Cuevas, P., Carceller, F. Neurol. Res. (2001) [Pubmed]
  21. Abolished angiogenicity and tumorigenicity of rat glioma by 1-naphthalenemonosulfonate. Cuevas, P., Carceller, F., Diaz, D., Reimers, D., Fernández, M., Lozano, R.M., González-Corrochano, R., Giménez-Gallego, G. Neurosci. Lett. (2001) [Pubmed]
  22. Fibroblast growth factors in myocardial ischemia / reperfusion injury and ischemic preconditioning. Cuevas, P., Carceller, F., Giménez-Gallego, G. J. Cell. Mol. Med. (2001) [Pubmed]
  23. Fibroblast growth factor cardioprotection against ischemia-reperfusion injury may involve K+ ATP channels. Cuevas, P., Carceller, F., Martinez-Coso, V., Asin-Cardiel, E., Giménez-Gallego, G. Eur. J. Med. Res. (2000) [Pubmed]
  24. Electromagnetic therapeutic angiogenesis: the next step. Cuevas, P., Asin-Cardiel, E. Neurol. Res. (2000) [Pubmed]
  25. Fibroblast growth factor protects the kidney against ischemia-reperfusion injury. Cuevas, P., Martinez-Coso, V., Fu, X., Orte, L., Reimers, D., Giménez-Gallego, G., Forssmann, W.G., Saenz De Tejada, I. Eur. J. Med. Res. (1999) [Pubmed]
  26. Apoptosis of glioma cells induced by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate. Cuevas, P., Reimers, D., Diaz, D., Lozano, R.M., Giménez-Gallego, G. Neurosci. Lett. (1999) [Pubmed]
  27. Cardioprotection from ischemia by fibroblast growth factor: role of inducible nitric oxide synthase. Cuevas, P., Carceller, F., Martinez-Coso, V., Cuevas, B., Fernandez-Ayerdi, A., Reimers, D., Asin-Cardiel, E., Giménez-Gallego, G. Eur. J. Med. Res. (1999) [Pubmed]
  28. Systemic administration of acidic fibroblast growth factor ameliorates the ischemic injury of the retina in rats. Cuevas, P., Carceller, F., Redondo-Horcajo, M., Lozano, R.M., Giménez-Gallego, G. Neurosci. Lett. (1998) [Pubmed]
  29. A non-mitogenic form of acidic fibroblast growth factor reduces neutrophil infiltration in rat ischemic reperfused heart. Cuevas, P., Carceller, F., Cuevas, B., Giménez-Gallego, G., Martinez-Coso, V. Eur. J. Med. Res. (1997) [Pubmed]
  30. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Cuevas, P., Reimers, D., Carceller, F., Martinez-Coso, V., Redondo-Horcajo, M., Saenz de Tejada, I., Giménez-Gallego, G. Eur. J. Med. Res. (1997) [Pubmed]
 
WikiGenes - Universities